D356-0231 Screening compound: N-(9-ethyl-9H-carbazol-3-yl)-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide

D356-0231 Screening compound: N-(9-ethyl-9H-carbazol-3-yl)-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide
D356-0231 Screening compound: N-(9-ethyl-9H-carbazol-3-yl)-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D356-0231
N-(9-ethyl-9H-carbazol-3-yl)-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D356-0231

Molecular Formula

C24H25N3O3S2 (C24 H25 N3 O3 S2)

Compound Name

N-(9-ethyl-9H-carbazol-3-yl)-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide

IUPAC name

N-(9-ethyl-9H-carbazol-3-yl)-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide

SMILES

CCn1c(ccc(NC(C(CC2)CCN2S(c2cccs2)(=O)=O)=O)c2)c2c2c1cccc2

InChI

InChI=1S/C24H25N3O3S2/c1-2-27-21-7-4-3-6-19(21)20-16-18(9-10-22(20)27)25-24(28)17-11-13-26(14-12-17)32(29,30)23-8-5-15-31-23/h3-10,15-17H,2,11-14H2,1H3,(H,25,28)

InChI Key

IPOLUCRDXLPTFK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02702054

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

467.61

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.663

Distribution Coefficient, logD

4.663

Water Solubility, LogSw

-4.30

Polar Surface Area

56.759

Acid Dissociation Constant (pKa)

13.36

Base Dissociation Constant (pKb)

-0.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

D356-0231 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS targets activity set (6557 compounds)

DGK Inhibitors Library (10558 compounds)

Human GPCR Annotated Library (5539 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with D356-0231 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D356-0231?
Check Price and Availability of D356-0231, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D356-0231 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D356-0231
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D356-0231
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D356-0231 available by request